NewzThe Trump administration announced Tuesday that it will end a Biden-era Medicare premium subsidy program after 2026, causing the subsidies for optional Medicare Part D prescription drug plans to expire at the end of next year. The administration stated the decision was made because the program allegedly benefited insurance companies more than enrollees.
The termination of the program will impact roughly 25 million Americans who are enrolled in standalone Medicare Part D drug plans. These individuals may soon see changes to their monthly premiums, as the subsidy program has helped keep those specific costs stable over the past two years.
In-depth summary · AI, neutral